Linglong Yin Selected Research

Neoplasms (Cancer)

8/2023	AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer.
3/2023	Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation.
1/2022	Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation-mediated CDC6 protein degradation.
11/2019	USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
1/2019	Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.
11/2018	FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness.
1/2017	The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linglong Yin Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 03/2017
7	Neoplasms (Cancer) 08/2023 - 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Carcinogenesis 11/2019
1	Residual Neoplasm 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Nasopharyngeal Carcinoma 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017

Drug/Important Bio-Agent (IBA)

2	abirateroneIBA 08/2023 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2017
2	taxaneIBA 11/2019 - 11/2018
1	Ran binding protein 9IBA 09/2023
1	PlatinumIBA 09/2023
1	RNA (Ribonucleic Acid)IBA 08/2023
1	enzalutamideIBA 08/2023
1	DiosgeninIBA 03/2023
1	Cantharidin (Cantharides)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	norcantharidinIBA 01/2022
1	bicalutamide (Casodex)FDA LinkGeneric 11/2021
1	ChromatinIBA 11/2021
1	Androgen Receptors (Androgen Receptor)IBA 11/2021
1	Deubiquitinating EnzymesIBA 11/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Forkhead Box Protein M1IBA 11/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2018
1	Histone Deacetylase InhibitorsIBA 07/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2018
1	olaparibIBA 07/2018
1	veliparibIBA 07/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2017
1	AndrogensIBA 03/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017

Therapy/Procedure

2	Castration 08/2023 - 01/2023
2	Therapeutics 03/2023 - 01/2017
2	Radiotherapy 01/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 09/2023